HCAR2 Orchestrates an Immunosuppressive Niche and Determines Checkpoint Inhibitor Responsiveness in Esophageal Squamous Cell Carcinoma
Zekun Li, Guangcong Shen, Xiaoqing Ma, Chenyang Meng, Diliyaer Abudukeremu, Rui Zhao, Zuoyu Chen, Qiang Song, Xiaofan Guo, Tianxing Zhou, Chao Xu, Bo Ni, Yueying Shan, Boyang Fu, Yiheng Chen, Zhansheng Jiang, Yongjie Xie, Kaiyuan Wang, Liangliang Wu, Xiuchao Wang · 2025
Read HCAR2 Orchestrates an Immunosuppressive Niche and Determines Checkpoint Inhibitor Responsiveness in Esophageal Squamous Cell Carcinoma by Zekun Li, Guangcong Shen, Xiaoqing Ma, Chenyang Meng, Diliyaer Abudukeremu, Rui Zhao, Zuoyu Chen, Qiang Song, Xiaofan Guo, Tianxing Zhou, Chao Xu, Bo Ni, Yueying Shan, Boyang Fu, Yiheng Chen, Zhansheng Jiang, Yongjie Xie, Kaiyuan Wang, Liangliang Wu, Xiuchao Wang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12831423.txt.
Description
Li and colleagues published in twenty twenty-five a study of a tumor subgroup in esophageal cancer that may predict immunotherapy response. This cancer is aggressive, and checkpoint drugs help only some patients. The team analyzed single-cell data from twelve patients receiving pre-surgery therapy. They found an epithelial subgroup marked by a receptor called HCAR2. Those cells carried high levels of the drug target PD-L1. Signals from them suppressed killer T cells through known pathways.
Lab and mouse tests confirmed the subgroup drives immune evasion. Patients with more of these cells had worse prognosis overall. Paradoxically, they also responded better to checkpoint therapy before surgery. Wider data sets confirmed the marker predicted favorable drug response. The authors propose HCAR2 as a dual-purpose biomarker. Targeting its pathway might boost immunotherapy for this cancer, they suggest.
Catalog record
| CREATOR | Zekun Li, Guangcong Shen, Xiaoqing Ma, Chenyang Meng, Diliyaer Abudukeremu, Rui Zhao, Zuoyu Chen, Qiang Song, Xiaofan Guo, Tianxing Zhou, Chao Xu, Bo Ni, Yueying Shan, Boyang Fu, Yiheng Chen, Zhansheng Jiang, Yongjie Xie, Kaiyuan Wang, Liangliang Wu, Xiuchao Wang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |